In the past week, OSCR stock has gone up by 8.81%, with a monthly gain of 11.10% and a quarterly plunge of -3.18%. The volatility ratio for the week is 8.37%, and the volatility levels for the last 30 days are 7.89% for Oscar Health Inc The simple moving average for the last 20 days is 8.55% for OSCR stock, with a simple moving average of -3.29% for the last 200 days.
Is It Worth Investing in Oscar Health Inc (NYSE: OSCR) Right Now?
The stock has a 36-month beta value of 1.69. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for OSCR is 176.26M, and at present, short sellers hold a 12.54% of that float. On March 10, 2025, the average trading volume of OSCR was 4.45M shares.
OSCR) stock’s latest price update
Oscar Health Inc (NYSE: OSCR)’s stock price has plunge by 2.88relation to previous closing price of 15.96. Nevertheless, the company has seen a 8.81% surge in its stock price over the last five trading sessions. seekingalpha.com reported 2025-03-09 that I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR’s opportunity in the ICHRA market is significant, with projections to increase 3x-5x by 2030, positioning it well against larger competitors. Risks include potential changes to ACA subsidies under future administrations, which could disrupt OSCR’s current business model and force a shift to ICHRA.
Analysts’ Opinion of OSCR
Many brokerage firms have already submitted their reports for OSCR stocks, with Jefferies repeating the rating for OSCR by listing it as a “Underperform.” The predicted price for OSCR in the upcoming period, according to Jefferies is $12 based on the research report published on December 10, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see OSCR reach a price target of $13.50, previously predicting the price at $21. The rating they have provided for OSCR stocks is “Underperform” according to the report published on November 06th, 2024.
UBS gave a rating of “Neutral” to OSCR, setting the target price at $23 in the report published on October 07th of the previous year.
OSCR Trading at 8.28% from the 50-Day Moving Average
After a stumble in the market that brought OSCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.98% of loss for the given period.
Volatility was left at 7.89%, however, over the last 30 days, the volatility rate increased by 8.37%, as shares surge +10.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.67% upper at present.
During the last 5 trading sessions, OSCR rose by +7.85%, which changed the moving average for the period of 200-days by -26.02% in comparison to the 20-day moving average, which settled at $15.12. In addition, Oscar Health Inc saw 22.17% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSCR starting from ALESSANDREA QUANE, who proposed sale 5,101 shares at the price of $16.50 back on Mar 07 ’25. After this action, ALESSANDREA QUANE now owns shares of Oscar Health Inc, valued at $84,181 using the latest closing price.
ALESSANDREA QUANE, the Officer of Oscar Health Inc, proposed sale 20,000 shares at $16.28 during a trade that took place back on Mar 05 ’25, which means that ALESSANDREA QUANE is holding shares at $325,654 based on the most recent closing price.
Stock Fundamentals for OSCR
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 1.0 for the gross margin
The net margin for Oscar Health Inc stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 2.80, with 0.64 for asset returns.
Based on Oscar Health Inc (OSCR), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 3.27. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is 2.41.
Currently, EBITDA for the company is 88.62 million with net debt to EBITDA at -13.82. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 29.05for trailing twelve months and the total asset turnover is 1.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
To sum up, Oscar Health Inc (OSCR) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
